Cart
sales@molnova.com
Tafenoquine Succinate
CAS No. 106635-81-8
Tafenoquine Succinate( WR 238605 (Succinate) )
Catalog No. M26474 CAS No. 106635-81-8
Tafenoquine Succinate is an 8-aminoquinoline. and is an agent of anti-malarial prophylactic.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 69 | In Stock |
|
| 2MG | 33 | In Stock |
|
| 5MG | 53 | In Stock |
|
| 10MG | 74 | In Stock |
|
| 25MG | 163 | In Stock |
|
| 50MG | 272 | In Stock |
|
| 100MG | 461 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTafenoquine Succinate
-
NoteResearch use only, not for human use.
-
Brief DescriptionTafenoquine Succinate is an 8-aminoquinoline. and is an agent of anti-malarial prophylactic.
-
DescriptionTafenoquine Succinate is an 8-aminoquinoline. and is an agent of anti-malarial prophylactic.(In Vivo):When tested at two times its ED100 (6 mg/kg), Tafenoquine anti-malarial activity is partially restored in humanized/CYP 2D6 knock-in mice .
-
In Vitro——
-
In Vivo——
-
SynonymsWR 238605 (Succinate)
-
PathwayOthers
-
TargetOther Targets
-
Recptormicrotubule
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number106635-81-8
-
Formula Weight581.589
-
Molecular FormulaC28H34F3N3O7
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (214.93 mM)
-
SMILESOC(=O)CCC(O)=O.COc1cc(C)c2c(Oc3cccc(c3)C(F)(F)F)c(OC)cc(NC(C)CCCN)c2n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Choi BH, Chattopadhaya S, Thanh le N, Feng L, Nguyen QT, Lim CB, Harikishore A, Nanga RP, Bharatham N, Zhao Y, Liu X, Yoon HS. Suprafenacine, an indazole-hydrazide agent, targets cancer cells through microtubule destabilization. PLoS One. 2014 Oct 29;9(10):e110955.
molnova catalog
related products
-
Cerdulatinib hydroch...
Cerdulatinib (PRT-062070) is an oral active, multi-targeted tyrosine kinase inhibitor with IC50 of 12 nM/6 nM/8 nM/0.5 nM and 32 nM for JAK1/JAK2/JAK3/TYK2 and Syk, respectively.
-
Apraglutide TFA
Apraglutide TFA (FE 203799 TFA), a synthetic 33-amino-acid peptide and a long-acting GLP-2 analogue, enhances adaptation and linear intestinal growth in a neonatal piglet model of short bowel syndrome with total resection of the ileum.
-
TK216
TK216 is a potent inhibitor of E26 transformation-specific (ETS) with anticancer activity.In DLBCL cell lines, TK216 (500 nM; for 24-72 hours) induces apoptosis.
